These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16178730)

  • 1. New therapeutic frontiers for metabotropic glutamate receptors.
    Niswender CM; Jones CK; Conn PJ
    Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological roles and therapeutic potential of metabotropic glutamate receptors.
    Conn PJ
    Ann N Y Acad Sci; 2003 Nov; 1003():12-21. PubMed ID: 14684432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
    O'Connor RM; Finger BC; Flor PJ; Cryan JF
    Eur J Pharmacol; 2010 Aug; 639(1-3):123-31. PubMed ID: 20371242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of metabotropic glutamate receptors.
    Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
    Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.
    Senter RK; Ghoshal A; Walker AG; Xiang Z; Niswender CM; Conn PJ
    Curr Neuropharmacol; 2016; 14(5):455-73. PubMed ID: 27296640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
    Lesage A; Steckler T
    Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.
    Lee JJ; Croucher MJ
    Neuroscience; 2003; 117(3):671-9. PubMed ID: 12617971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
    Luján-Miras R
    Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
    Palucha A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1545-53. PubMed ID: 17107280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.
    Spooren WP; Gasparini F; Salt TE; Kuhn R
    Trends Pharmacol Sci; 2001 Jul; 22(7):331-7. PubMed ID: 11431019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications.
    Slassi A; Isaac M; Edwards L; Minidis A; Wensbo D; Mattsson J; Nilsson K; Raboisson P; McLeod D; Stormann TM; Hammerland LG; Johnson E
    Curr Top Med Chem; 2005; 5(9):897-911. PubMed ID: 16178734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
    Litim N; Morissette M; Di Paolo T
    Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.
    Yin S; Noetzel MJ; Johnson KA; Zamorano R; Jalan-Sakrikar N; Gregory KJ; Conn PJ; Niswender CM
    J Neurosci; 2014 Jan; 34(1):79-94. PubMed ID: 24381270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.
    Yin S; Zamorano R; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():122-32. PubMed ID: 22426233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological agents acting at subtypes of metabotropic glutamate receptors.
    Schoepp DD; Jane DE; Monn JA
    Neuropharmacology; 1999 Oct; 38(10):1431-76. PubMed ID: 10530808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.
    Gasparini F; Kuhn R; Pin JP
    Curr Opin Pharmacol; 2002 Feb; 2(1):43-9. PubMed ID: 11786307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
    Sheffler DJ; Pinkerton AB; Dahl R; Markou A; Cosford ND
    ACS Chem Neurosci; 2011 Aug; 2(8):382-93. PubMed ID: 22860167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors as drug targets.
    Récasens M; Guiramand J; Aimar R; Abdulkarim A; Barbanel G
    Curr Drug Targets; 2007 May; 8(5):651-81. PubMed ID: 17504108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
    Ritzén A; Mathiesen JM; Thomsen C
    Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):202-13. PubMed ID: 16176554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.